
Releases
Acurx and Leiden University Partner to Target MRSA DNA Replication
Acurx Pharmaceuticals has launched a scientific collaboration with Leiden University Medical Center to map the 3D structure of DNA polymerase IIIC in methicillin-resistant Staphylococcus aureus. This research aims to accelerate the development of systemic antibiotics that bypass traditional resistance mechanisms while sparing the patient's gut microbiome.

























